Dharmin D Desai1, E L Johnson2, Ivan L Cordrey1. 1. Radiation Oncology, CHI Memorial Hospital, Chattanooga, TN, USA. 2. Department of Radiation Medicine, University of Kentucky Chandler Medical Center, Lexington, KY, USA.
Abstract
PURPOSE: Stereotactic radiosurgery (SRS) is rapidly becoming the standard of care for many intracranial targets. The characteristics of the planning target volume (PTV) can affect the intermediate dose spill and thus normal brain volume dose which is correlated with brain toxicity. R50% (volume receiving 50% of prescription dose divided by PTV volume) is a useful metric to quantify the intermediate dose spill. We propose a novel understanding of how the PTV surface area (SAPTV ) affects the intermediate dose spill of SRS treatments. METHODS: Using a phantom model provided by a computed tomography (CT) of the IROC Head Phantom® and Eclipse® Treatment Planning System, we investigate the relationship of R50% and SAPTV in single-target SRS treatments. The planning studies are conducted for SRS treatments on a Varian TrueBeam® linear accelerator with high-definition MLC and a 6 MVFFF beam mode. These data are analyzed to ascertain trends in R50% related to SAPTV . Since SAPTV is not available as a structure property in the Eclipse RTPS, we introduce an Eclipse script to extract PTV surface area of arbitrary-shaped PTVs. We compare a physically reasonable theoretical prediction of R50%, R50%Analytic , to the R50% achieved in treatment planning studies. RESULTS: The SRS phantom study indicates good correlation between the plan R50% and SAPTV . A near-linear relationship of plan R50% vs SAPTV is observed as predicted by the R50%Analytic model. Agreement between plan R50% values and R50%Analytic predictions is good for all but the very smallest PTV volumes. CONCLUSIONS: We demonstrate dependence of the intermediate dose spill measured by R50% on the SAPTV . We call that dependence the surface area effect. This dependence is explicit in the R50%Analytic prediction model. The predicted value of R50%Analytic for a given PTV could be used for guidance during SRS treatment plan optimization, and plan evaluation for that PTV.
PURPOSE: Stereotactic radiosurgery (SRS) is rapidly becoming the standard of care for many intracranial targets. The characteristics of the planning target volume (PTV) can affect the intermediate dose spill and thus normal brain volume dose which is correlated with brain toxicity. R50% (volume receiving 50% of prescription dose divided by PTV volume) is a useful metric to quantify the intermediate dose spill. We propose a novel understanding of how the PTV surface area (SAPTV ) affects the intermediate dose spill of SRS treatments. METHODS: Using a phantom model provided by a computed tomography (CT) of the IROC Head Phantom® and Eclipse® Treatment Planning System, we investigate the relationship of R50% and SAPTV in single-target SRS treatments. The planning studies are conducted for SRS treatments on a Varian TrueBeam® linear accelerator with high-definition MLC and a 6 MVFFF beam mode. These data are analyzed to ascertain trends in R50% related to SAPTV . Since SAPTV is not available as a structure property in the Eclipse RTPS, we introduce an Eclipse script to extract PTV surface area of arbitrary-shaped PTVs. We compare a physically reasonable theoretical prediction of R50%, R50%Analytic , to the R50% achieved in treatment planning studies. RESULTS: The SRS phantom study indicates good correlation between the plan R50% and SAPTV . A near-linear relationship of plan R50% vs SAPTV is observed as predicted by the R50%Analytic model. Agreement between plan R50% values and R50%Analytic predictions is good for all but the very smallest PTV volumes. CONCLUSIONS: We demonstrate dependence of the intermediate dose spill measured by R50% on the SAPTV . We call that dependence the surface area effect. This dependence is explicit in the R50%Analytic prediction model. The predicted value of R50%Analytic for a given PTV could be used for guidance during SRS treatment plan optimization, and plan evaluation for that PTV.
Authors: Grant M Clark; Richard A Popple; Brendan M Prendergast; Sharon A Spencer; Evan M Thomas; John G Stewart; Barton L Guthrie; James M Markert; John B Fiveash Journal: Pract Radiat Oncol Date: 2012-01-30
Authors: Brian J Blonigen; Ryan D Steinmetz; Linda Levin; Michael A Lamba; Ronald E Warnick; John C Breneman Journal: Int J Radiat Oncol Biol Phys Date: 2009-09-23 Impact factor: 7.038
Authors: Haisong Liu; David W Andrews; James J Evans; Maria Werner-Wasik; Yan Yu; Adam Paul Dicker; Wenyin Shi Journal: Front Oncol Date: 2016-02-11 Impact factor: 6.244